NUMELVI is a tablet taken once daily, serving as the first-line treatment and the only second-generation Janus kinase (JAK) inhibitor specifically designed to treat itch associated with allergic dermatitis, including atopic allergic dermatitis, and to manage the clinical symptoms of atopic allergic dermatitis in dogs. NUMELVI – the next generation of itch relief – is a new product for managing allergic dermatitis in dogs, offering selectivity, safety, and simplicity. Active Ingredients NUMELVI contains Atinvicitinib. Indications For the treatment of itch associated with allergic dermatitis, including atopic allergic dermatitis in dogs. For the treatment of inflammation and clinical symptoms of atopic allergic dermatitis in dogs.
Expires on February 28, 2029